|En la categoría:
No quedan existencias de este artículo.
¿Quieres vender uno?

Fibromyalgia (Oxford American Respi..., Wallace, MD Dan

worldofbooksinc
(238081)
Registrado como vendedor profesional
USD8,39
Aproximadamente7,16 EUR
Estado:
En muy buen estado
Envío:
Gratis USPS Media MailTM.
Ubicado en: Montgomery Illinois, Estados Unidos
Entrega:
Entrega prevista entre el jue. 28 ago. y el jue. 4 sep. a 94104
Calculamos el plazo de entrega con un método patentado que combina diversos factores, como la proximidad del comprador a la ubicación del artículo, el servicio de envío seleccionado, el historial de envíos del vendedor y otros datos. Los plazos de entrega pueden variar, especialmente en épocas de mucha actividad.
Devoluciones:
30 días para devoluciones. El vendedor paga el envío de la devolución.
Pagos:
    Diners Club

Compra con confianza

Garantía al cliente de eBay
Si no recibes el artículo que has pedido, te devolvemos el dinero. Más informaciónGarantía al cliente de eBay - se abre en una nueva ventana o pestaña
El vendedor asume toda la responsabilidad de este anuncio.
N.º de artículo de eBay:355877381027
Última actualización el 08 jul 2025 16:29:19 H.EspVer todas las actualizacionesVer todas las actualizaciones

Características del artículo

Estado
En muy buen estado: Libro que se ha leído y que no tiene un aspecto nuevo, pero que está en un ...
Book Title
Fibromyalgia (Oxford American Respiratory Library)
ISBN
0195384415
EAN
9780195384413
Release Title
Fibromyalgia (Oxford American Respiratory Library)
Artist
Wallace, MD Daniel
Brand
N/A
Colour
N/A

Acerca de este producto

Product Identifiers

Publisher
Oxford University Press, Incorporated
ISBN-10
0195384415
ISBN-13
9780195384413
eBay Product ID (ePID)
108430293

Product Key Features

Number of Pages
112 Pages
Publication Name
Fibromyalgia
Language
English
Publication Year
2010
Subject
Pain Medicine, Allied Health Services / Respiratory Therapy
Type
Textbook
Author
Daniel Wallace, Daniel Clauw
Subject Area
Medical
Series
Oxford American Respiratory Library
Format
Trade Paperback

Dimensions

Item Height
0.3 in
Item Weight
7.1 Oz
Item Length
4.8 in
Item Width
7.8 in

Additional Product Features

Intended Audience
Scholarly & Professional
LCCN
2008-035016
Number of Volumes
1 vol.
Illustrated
Yes
Table Of Content
1. History of fibromyalgia2. Definitions and classification3. Epidemiology4. Pathogenesis and basic science5. Clinical findings---symptoms and signs6. Laboratory and imaging correlates7. Clinical associations and subsets8. Differential diagnosis9. Methods of ascertainment used for clinical trials10. General concepts of treatment11. Medications used to manage fibromyalgia12. Economic impact and disability issues13. Prognosis14. Experimental and innovative therapiesAppendix Resource information
Synopsis
Characterized by chronic widespread pain, fibromyalgia presents complex problems in both its diagnosis and treatment. Fibromyalgia is a fairly common condition, affecting 2-4% of the population. The condition's prevalence has increased dramatically since 1990. The condition is not new, but has been known by various names, such as fibrositis and myofascial pain syndrome until 1990, when the American College of Rheumatology (ACR) published new classification criteria and first used the name fibromyalgia. The absence of objective diagnostic testing and the overlap with other condition often leads to a significant delay in diagnosis. There is a general misconception that the condition is unresponsive to treatment. However, published research shows that diagnosing and managing fibromyalgia leads to meaningful improvement in the patient's symptons and quality of life. Patients with fibromyalgia often demonstrate symptons additional to pain and are consquently diagnosed with one or more co-occurring syndromes and conditions, complicating diagnosis and treatment. The comorbidities most commonly associated wtih fibromyalgia are sleep disturbance, depression, anxiety, and other psychiatric disorders. Another condition frequently demonstrated by fibromylgia patients is irritable bowel syndrome. Chronic fatigue syndrome also commonly co-occurs, and is often confused wtih fibromyalgia upon initial diagnosis. Numerous pharmacological therapy options exist to treat pain and related symptons of fibromyalgia. Achievement of desired treatment outcomes requires careful patient selection, drug administration and monitoring. Accurate diagnosis of chronic pain syndromes is critical, as some commonly used medications to treat many pain conditions are relatively ineffective wtih fibromyalgia. Despite increasing recognition as a relatively common cause of chronic pain, fibromyalgia continues to generate controversy among clinicians. Given the intricate and challenging nature of treating fibromyalgia and comorbid disorders, it is imperative to educate primary care providers on the initial symptons, complications, and treatment strategies for fibromyalgia, as most patients with the condition will see a primary care provider for initial diagnosis/referral, and follow-up-care. In the years since the release of the ACR criteria, increasing recognition and advances in research have provided key insights into the etiology of fibromyalgia, resulting in the use of several successful pharmacological, as well as non-pharmacological, treatment approaches. However, despite the efforts of professional medical organizations and patient care groups, awareness of the current state of clinical assessment and treatment of fibromyalgia by healthcare professionals continues to be lacking. This book is designed to provide a succint and practical guide to help primary care physicians, internists, specialists, and allied health professionals effectively diagnose and manage patients with fibromyalgia. This concise volume will provide an essential understanding of the pathophysiology of the pain, subtypes, and pitfalls in the diagnosis of this chronic condition., Characterized by chronic widespread pain, fibromyalgia presents complex problems in both its diagnosis and treatment. Fibromyalgia is a fairly common condition, affecting 2-4% of the population. The condition's prevalence has increased dramatically since 1990. The condition is not new, but has been known by various names, such as fibrositis and myofascial pain syndrome until 1990, when the American College of Rheumatology (ACR) published new classification criteria and first used the name fibromyalgia. The absence of objective diagnostic testing and the overlap with other condition often leads to a significant delay in diagnosis. There is a general misconception that the condition is unresponsive to treatment. However, published research shows that diagnosing and managing fibromyalgia leads to meaningful improvement in the patient's symptons and quality of life.Patients with fibromyalgia often demonstrate symptons additional to pain and are consquently diagnosed with one or more co-occurring syndromes and conditions, complicating diagnosis and treatment. The comorbidities most commonly associated wtih fibromyalgia are sleep disturbance, depression, anxiety, and other psychiatric disorders. Another condition frequently demonstrated by fibromylgia patients is irritable bowel syndrome. Chronic fatigue syndrome also commonly co-occurs, and is often confused wtih fibromyalgia upon initial diagnosis. Numerous pharmacological therapy options exist to treat pain and related symptons of fibromyalgia. Achievement of desired treatment outcomes requires careful patient selection, drug administration and monitoring. Accurate diagnosis of chronic pain syndromes is critical, as some commonly used medications to treat many pain conditions are relatively ineffective wtih fibromyalgia.Despite increasing recognition as a relatively common cause of chronic pain, fibromyalgia continues to generate controversy among clinicians. Given the intricate and challenging nature of treating fibromyalgia and comorbid disorders, it is imperative to educate primary care providers on the initial symptons, complications, and treatment strategies for fibromyalgia, as most patients with the condition will see a primary care provider for initial diagnosis/referral, and follow-up-care. In the years since the release of the ACR criteria, increasing recognition and advances in research have provided key insights into the etiology of fibromyalgia, resulting in the use of several successful pharmacological, as well as non-pharmacological, treatment approaches. However, despite the efforts of professional medical organizations and patient care groups, awareness of the current state of clinical assessment and treatment of fibromyalgia by healthcare professionals continues to be lacking.This book is designed to provide a succint and practical guide to help primary care physicians, internists, specialists, and allied health professionals effectively diagnose and manage patients with fibromyalgia. This concise volume will provide an essential understanding of the pathophysiology of the pain, subtypes, and pitfalls in the diagnosis of this chronic condition., This book is designed to provide a succinct and practical guide to help primary care physicians, internists, specialists, and allied health professionals effectively diagnose and manage patients with fibromyalgia. This concise volume will provide an essential understanding of the pathophysiology of the pain, subtypes, and pitfalls in the diagnosis and management of this chronic condition. Designed to help eradicate misconceptions concerning fibromyalgia, includingthe ineffectiveness of treatment, this concise volume helps clinicians to understand and then effectively diagnosis and treat patients with the disorder. Ideal for busy clinicians at the point ofcare, Fibromyalgia presents an overview of the condition, including its epidemiology, symptoms, signs, and classification, as well as instructs healthcare professionals in the assessment and treatment of fibromyalgia patients.
LC Classification Number
RC927.3.W345 2008

Descripción del artículo del vendedor

Información de vendedor profesional

Certifico que todas mis actividades de venta cumplirán todas las leyes y reglamentos de la UE.
Acerca de este vendedor

worldofbooksinc

97,7% de votos positivos1,2 millones artículos vendidos

Se unió el feb 2020
Suele responder en 24 horas
Registrado como vendedor profesional
In 2002, World of Books Group was founded on an ethos to do good, protect the planet and support charities by enabling more goods to be reused. Since then, we've grown into to a global company ...
Ver más
Visitar tiendaContactar

Valoraciones detalladas sobre el vendedor

Promedio durante los últimos 12 meses
Descripción precisa
4.8
Gastos de envío razonables
5.0
Rapidez de envío
5.0
Comunicación
5.0

Votos de vendedor (274.590)

Todas las valoraciones
Positivas
Neutras
Negativas
    • s***. (1826)- Votos emitidos por el comprador.
      Mes pasado
      Compra verificada
      Awesome Transaction. Item arrived quickly and as described. Thank you
    Ver todos los votos